Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The global artificial intelligence in pharmaceuticals market was valued at USD 4.31 Billion in 2025. It is poised to grow at a CAGR of 29.90% during the forecast period of 2026-2035, and reach USD 58.96 Billion by 2035. The market growth is driven by the increasing complexity of drug safety and efficacy requirements. AI-based tools are being widely deployed for drug interaction prediction, enabling early identification of adverse effects and improving overall patient safety.
Q1 2026 Market Updates
Overview: Q1 2026 brought a distinctive set of pressures to the Artificial Intelligence In Pharmaceuticals industry, shaped by the Iran-US-Israel conflict. Demand signals for the global artificial intelligence in pharmaceuticals market through healthcare system stress-testing, defense medical digitalization, and the validation of remote care and AI-enabled health technology under conflict-proximate conditions. Conflict-driven healthcare system overload, with Israeli hospitals managing exceptional casualty volumes and Gulf state healthcare systems maintaining continuity during regional uncertainty, proved out the operational importance of digital health platforms, AI clinical decision support, and remote patient monitoring technology. Shield AI's defense AI validation (Shield AI reaching a $12.7 billion valuation (CNBC, March 28, 2026)) and Palantir Maven's deployment (Palantir Maven AI deployed by US and allied forces (Alex Karp, CNBC, March 28, 2026)) reinforce the broader AI technology investment environment that is accelerating AI adoption in healthcare settings.
United States: American buyers and producers alike found that In the US, US artificial intelligence in pharmaceuticals market demand over Q1 2026 was elevated by defense healthcare digitalization, with military medical facilities adopting advanced clinical IT, AI decision support, and telemedicine platforms to manage elevated caseload from Q1 2026 military operations. US hospital systems invested in cyber security hardening for health IT infrastructure, with Q1 2026 conflict-adjacent cyber threat environment motivating healthcare cyber security investment acceleration. US healthcare AI investment, with companies like Tempus, Veracyte, and emerging AI health startups attracting elevated funding, was reinforced by Q1 2026's validation of AI-enabled decision-making in high-pressure environments. CMS reimbursement expansion for digital health services maintained commercial adoption momentum independent of Q1 2026 disruption.
Iran & Israel: Israel's digital health sector, one of the world's most advanced per-capita medtech ecosystems, demonstrated operational resilience throughout Q1 2026, with health IT systems, telemedicine platforms, and AI diagnostic tools maintaining functionality under conflict-proximate conditions. Israeli digital health companies, including Zebra Medical Vision, MedAware, and dozens of AI diagnostics startups, continued operations and attracted investor attention as conflict proved out the operational value of AI-enabled clinical tools. Gulf state digital health investment, Vision 2030 healthcare digitalization and UAE's Smart Dubai health platform programs, maintained procurement of artificial intelligence in pharmaceuticals market platforms supported by elevated oil revenues from Brent crude at USD 126/barrel (Wikipedia). Iran's healthcare IT infrastructure, already severely constrained by international software and technology sanctions, faced additional Q1 2026 disruption to digital health capability maintenance.
Key Takeaways
Government & Policy Watch
- Defense healthcare IT: US military medical facility digital health investment is elevated by Q1 2026 operational demands, with AI clinical decision support, telemedicine, and healthcare cyber security receiving accelerated procurement authorization.
- Cyber security investment: Q1 2026 elevated cyber threat environment is accelerating healthcare IT security investment, with hospital systems hardening EHR, medical device, and health analytics infrastructure against state-sponsored cyber attack.
- AI validation: Q1 2026 AI system validation at scale, Shield AI's $12.7B valuation and Palantir Maven deployment, reinforces healthcare investor confidence in AI platform investment across clinical decision support and diagnostics applications.
Market & Industry Impact
- Market growth: The artificial intelligence in pharmaceuticals market is growing on AI adoption, cloud migration, interoperability mandates, remote care expansion, and value-based care data requirements, with Q1 2026 providing near-term defense healthcare IT demand acceleration.
- AI in clinical care: AI-enabled clinical decision support, medical imaging analysis, and predictive patient monitoring are one of the faster-growing artificial intelligence in pharmaceuticals market segments, with large language model integration creating new capability dimensions.
- Telehealth permanence: Post-pandemic telehealth permanence, reinforced by Q1 2026 remote care operational validation, continues to drive digital health platform investment across outpatient, chronic care, and mental health service delivery.
Procurement & Supply Chain Alert
- Cyber security risk: Healthcare IT systems represent high-value cyber attack targets, with Q1 2026 conflict-adjacent state-sponsored cyber threat environment creating elevated ransomware, data breach, and system disruption risk for health IT operators.
- Interoperability complexity: Artificial intelligence in pharmaceuticals market system integration with legacy EHR, medical device, and administrative systems requires extensive API development and data standardization investment, a technical barrier that constrains rapid deployment.
- Regulatory compliance: Digital health products face FDA Software as a Medical Device (SaMD) regulation, HIPAA privacy requirements, and ONC interoperability rules, a multi-framework compliance environment that adds cost and timeline to product development.
Key Market Trends and Insights
- By application, drug discovery and pre-clinical development accounted for nearly 34% of the market during the historical period.
- Based on region, North America held an approximate 41% share of the artificial intelligence in pharmaceuticals market in the historical period.
- By technology, deep learning dominated with around 38% share of the market during the historical period.
Market Size and Forecast
- Market Size (2025): USD 4.31 Billion
- Projected Market Size (2035): USD 58.96 Billion
- CAGR (2026-2035): 29.90%
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
In February 2026, Takeda partnered with Iambic Therapeutics in a USD 1.7 billion deal to advance AI drug development, leveraging AI models to accelerate drug discovery timelines and improve candidate success rates.
-
In March 2026, MSD expanded AI deployment, strengthening pharmaceutical manufacturing AI, doubling molecule generation, and accelerating development pipelines efficiently.
-
In March 2025, Isomorphic Labs raised USD 600 million to advance AI drug development, enhancing its AI design engine and accelerating drug candidates toward clinical development.
Compound Annual Growth Rate
29.9%
Value in USD Billion
2026-2035
*this image is indicative*
Artificial Intelligence in Pharmaceuticals Market Overview
Artificial intelligence is steadily transforming the pharmaceutical industry by improving efficiency across discovery, development, and commercialization. The integration of advanced analytics and machine learning models has significantly accelerated AI drug development, enabling researchers to identify viable candidates with greater precision and reduced timelines. At the same time, companies are leveraging intelligent systems to streamline clinical trial optimization, improving patient recruitment, protocol design, and trial outcomes. In addition, the growing adoption of pharmacovigilance AI is enhancing post-marketing surveillance by enabling faster detection of adverse drug reactions and safety signals. The market reached a value of approximately USD 4.31 Billion in 2025.
Artificial Intelligence in Pharmaceuticals Market Growth Drivers
Rising Strategic Investments in AI-Driven Drug Discovery to Propel the Market Value
Rising R&D costs and increasing demand for faster drug discovery are key drivers fueling market growth. For instance, in February 2026, Takeda announced a USD 1.7 billion partnership with Iambic Therapeutics to advance AI drug development, focusing on predictive modeling and faster candidate identification. Such large-scale investments highlight growing confidence in AI’s ability to improve success rates and reduce development timelines, ultimately accelerating innovation and strengthening competitive positioning across the global pharmaceutical industry.
Artificial Intelligence in Pharmaceuticals Market Trends
Key trends shaping the market include rising adoption of AI, improved efficiency, and accelerated drug development processes.
Increasing Integration of AI Across the Pharmaceutical Value Chain to Boost the Market Expansion
Growing demand for operational efficiency and increasing digital transformation across pharmaceutical production are key drivers supporting market expansion. For instance, in March 2026, MSD highlighted expanding AI deployment across discovery, development, and manufacturing, significantly strengthening pharmaceutical manufacturing AI capabilities. The company reported doubling molecule generation and advancing candidates into trials while maintaining human oversight. This reflects a broader industry shift toward integrated AI adoption, enabling faster innovation cycles, improved pipeline productivity, and more efficient drug discovery processes globally.
Artificial Intelligence in Pharmaceuticals Market Segmentation
Market Breakup by Technology
- Natural Language Processing
- Context-Aware Processing
- Deep Learning
- Querying Method
- Others
Market Breakup by Drug Type
- Large Molecule
- Small Molecule
Market Breakup by Application
- Drug Discovery
- Research and Development
- Clinical Trial
- Treatment Planning and Personalization
- Others
Market Breakup by End User
- Pharmaceutical and Biopharmaceutical Companies
- Academic and Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Afric
Artificial Intelligence in Pharmaceuticals Market Share
Deep Learning Likely to Lead the Market Segment by Technology
Deep learning emerged as the leading technology, accounting for nearly 38% share in the historical period, driven by its ability to process complex biomedical datasets. Its growing use in AI drug development has significantly improved target identification and molecule screening. Additionally, applications in clinical trial optimization are enhancing trial design and patient selection, reinforcing deep learning’s dominance as pharmaceutical companies increasingly prioritize efficiency, accuracy, and reduced development timelines.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Global Artificial Intelligence in Pharmaceuticals Market Analysis by Region
North America accounted for approximately 41% share of the market in the historical period, supported by strong technological infrastructure and early AI adoption. The region benefits from advanced use of pharmacovigilance AI to monitor drug safety and increasing reliance on real-world evidence for regulatory and clinical decision-making. Moreover, the presence of leading pharmaceutical and technology firms continues to drive innovation and regional market growth.
Leading Players in the Artificial Intelligence in Pharmaceuticals Market
The key features of the market report comprise patent analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
IBM Corporation
IBM Corporation is a key player in the market, offering advanced AI-driven solutions that enhance drug discovery, clinical trial efficiency, and personalized treatment. Through its AI technology, including IBM Watson Health, the company supports real-time medical imaging analysis, predictive models for disease detection, and automated data processing, strengthening clinical trial optimization and accelerating pharmaceutical research and patient outcomes.
Deep Genomics
Deep Genomics is a biotechnology company pioneering the use of artificial intelligence in pharmaceutical research, particularly RNA therapeutics. Its proprietary AI platform, BigRNA, the world’s first RNA foundation model, leverages advanced machine learning to identify novel biological mechanisms and design RNA-based drug candidates, significantly advancing AI drug development and accelerating therapeutic discovery through genomics-driven innovation.
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. is a prominent player specializing in AI-driven drug discovery and development. Leveraging generative AI, the company accelerates target evaluation, molecule design, and clinical study planning. It collaborates with pharmaceutical and biotech firms to enhance efficiency and success rates, while integrating advanced drug interaction prediction capabilities to optimize safety and therapeutic effectiveness during development.
Microsoft Corporation
Microsoft Corporation plays a pivotal role in advancing the market through AI-powered solutions that enhance drug discovery and development. Leveraging machine learning and data analytics, the company enables pharmaceutical firms to utilize real-world evidence for improved decision-making, supporting target identification, predictive modeling, and accelerated research timelines while driving cost efficiency and precision medicine initiatives.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Exscientia, NVIDIA Corporation, Insilico Medicine, Atomwise, Inc., Biosymetrics, and Euretos.
Key Questions Answered in the Artificial Intelligence in Pharmaceuticals Market Report
- What was the artificial intelligence in pharmaceuticals market value in 2025?
- What is the artificial intelligence in pharmaceuticals market forecast outlook for 2026-2035?
- What major factors aid the demand for artificial intelligence in pharmaceuticals market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major artificial intelligence in pharmaceuticals market trends?
- Which technology is projected to lead the market segment?
- Which drug type is expected to dominate the market segment?
- Which application is likely to lead the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players in the artificial intelligence in pharmaceuticals market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Drug Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share